CIMZIAINOFFICE.COM: Keyword Density Checker

Total words: 5064 | 2-word phrases: 1331 | 3-word phrases: 1536 | 4-word phrases: 1599

PAGE INFO

Title	Try to keep the title under 60 characters (49 characters) CIMZIA® (certolizumab pegol) In-Office Injection
Description	Try to keep the meta description between 50 - 160 characters (96 characters) CIMZIA® (certolizumab pegol) In-Office Injection for HCPs. Access full Prescribing Information.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	with tnf blocker	6	0.39%
2	with tnf blockers	6	0.39%
3	have been reported	5	0.33%
4	treatment of adult	5	0.33%
5	treated with tnf	4	0.26%
6	treatment with cimzia	4	0.26%
7	invasive fungal infections	4	0.26%
8	patients treated with	4	0.26%
9	with cimzia in	4	0.26%
10	patients with a	4	0.26%
11	the risks and	3	0.20%
12	tnf blockers including	3	0.20%
13	request a rep	3	0.20%
14	fatal have been	3	0.20%
15	been reported in	3	0.20%
16	signs and symptoms	3	0.20%
17	and benefits of	3	0.20%
18	risks and benefits	3	0.20%
19	patients with active	3	0.20%
20	and symptoms of	3	0.20%
21	reported with tnf	3	0.20%
22	of adults with	3	0.20%
23	treatment of adults	3	0.20%
24	important safety information	3	0.20%
25	adult patients with	3	0.20%
26	trademarks and registered	2	0.13%
27	and registered trademarks	2	0.13%
28	registered trademarks are	2	0.13%
29	trademarks are the	2	0.13%
30	cimzia inoffice injection	2	0.13%

#	Keyword	Frequency	Density
1	treated with tnf blockers	4	0.25%
2	patients treated with tnf	3	0.19%
3	risks and benefits of	3	0.19%
4	treatment of adults with	3	0.19%
5	fatal have been reported	3	0.19%
6	signs and symptoms of	3	0.19%
7	the risks and benefits	3	0.19%
8	registered trademarks are the	2	0.13%
9	infection during and after	2	0.13%
10	treatment of adult patients	2	0.13%
11	of adult patients with	2	0.13%
12	trademarks of the ucb	2	0.13%
13	adult patients with active	2	0.13%
14	have been reported in	2	0.13%
15	of the ucb group	2	0.13%
16	some fatal have been	2	0.13%
17	malignancies some fatal have	2	0.13%
18	are registered trademarks of	2	0.13%
19	tnf blockers including cimzia	2	0.13%
20	serum sickness and urticaria	2	0.13%
21	their respective owners ©2024	2	0.13%
22	all other trademarks and	2	0.13%
23	consider the risks and	2	0.13%
24	other trademarks and registered	2	0.13%
25	trademarks and registered trademarks	2	0.13%
26	smyrna ga 30080 all	2	0.13%
27	inc smyrna ga 30080	2	0.13%
28	ucb inc smyrna ga	2	0.13%
29	©2024 ucb inc smyrna	2	0.13%
30	owners ©2024 ucb inc	2	0.13%
31	respective owners ©2024 ucb	2	0.13%
32	and registered trademarks are	2	0.13%
33	registered trademarks of the	2	0.13%
34	with tnf blockers of	2	0.13%
35	cimzia is a member	2	0.13%
36	reported with tnf blocker	2	0.13%
37	for use in pediatric	2	0.13%
38	indicated for use in	2	0.13%
39	tnf blockers of which	2	0.13%
40	reported with tnf blockers	2	0.13%

#	URL	Whois	Check
1	https://www.cimzia.com/sites/default/files/docs/CIMZIA_full_prescribing_information.pdf	Whois	cimzia.com
2	https://www.cimzia.com	Whois	cimzia.com
3	https://www.cimzia.com/sites/default/files/docs/CIMZIA_full_prescribing_information.pdf	Whois	cimzia.com
4	http://cimziahcp.com/privacy-policy	Whois	cimziahcp.com
5	http://cimziahcp.com/terms-of-use	Whois	cimziahcp.com
6	http://cimziahcp.com/about-ucb	Whois	cimziahcp.com
7	https://www.ucb-usa.com/Contact/Contact-Us	Whois	ucb-usa.com
8	https://www.cimziahcp.com/privacy-policy	Whois	cimziahcp.com
9	https://www.cimziahcp.com/privacy-policy	Whois	cimziahcp.com